National Research Corporation (NRC) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential
Current Price
$19.53
Price Target
—
Target Range
— — —
Analyst Rating
—
Forward P/E22.2x
Trailing P/E37.6x
Forward PEG—
Implied Growth+113.4%
Median Target—
Analyst Spread—
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$—
—
Consensus
$—
—
Bull Case
$—
—
Valuation Model TargetsConfidence: 42/100
Bear$23
Base$26
Bull$70
NRC Price Target Analysis
Updated May 30, 2026As of May 30, 2026, National Research Corporation (NRC) has a Wall Street consensus price target of N/A, based on estimates from 0 covering analysts. The company has a market capitalization of $440M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is N/A, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, NRC trades at a trailing P/E of 37.6x and forward P/E of 22.2x. Analysts expect EPS to grow +113.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $26.05, with bear and bull scenarios of $23.18 and $70.45 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+33.9%
Avg Forward P/E19.0x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SATSEchoStar Corporation | $37.2B | $129.19 | $136.40 | +5.6% | Buy | — | 11 |
 FORRForrester Research, Inc. | $135M | $7.05 | — | — | Hold | 9.2x | 4 |
 CSGPCoStar Group, Inc. | $13.6B | $32.20 | $61.18 | +90.0% | Buy | 23.6x | 25 |
 MORNMorningstar, Inc. | $6.9B | $182.02 | $236.50 | +29.9% | Hold | 15.3x | 6 |
 QNSTQuinStreet, Inc. | $719M | $12.52 | $15.00 | +19.8% | Buy | 10.3x | 13 |
 HCATHealth Catalyst, Inc. | $102M | $1.38 | $2.25 | +63.0% | Buy | 35.6x | 22 |
 PINCPremier, Inc. | $2.3B | $28.26 | $33.15 | +17.3% | Hold | 20.8x | 31 |
 HQYHealthEquity, Inc. | $7.4B | $87.99 | $109.89 | +24.9% | Buy | 22.2x | 27 |
 TDOCTeladoc Health, Inc. | $1.4B | $7.61 | $7.58 | -0.4% | Hold | — | 42 |
 CERTCertara, Inc. | $905M | $5.82 | $9.00 | +54.6% | Buy | 15.2x | 16 |
Upside Potential Comparison
CSGPHCATCERTMORNHQYQNSTPINCSATSWhat if you invested $1,000 in NRC 10 years ago?
Total return calculator · dividends reinvested
Calculate ReturnsHow much would $100/month in NRC be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs NRC Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationNRC vs DBVT — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs DBV Technologies S.A..
Compare NowNRC — Frequently Asked Questions
Quick answers to the most common questions about buying NRC stock.
What is the NRC stock price target for 2026?
The consensus price target for NRC is $N/A, close to the current price of $19.53 (N/A% implied move). Based on 0 analyst estimates, the stock appears fairly valued near current levels.
Is NRC a buy, sell, or hold?
NRC has a consensus rating of "N/A" based on 0 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
Is NRC stock overvalued or undervalued?
NRC trades at a forward P/E of 22.1932x, representing a moderate valuation. With analysts targeting $N/A (N/A% implied move), the stock appears close to fair value.
How high can NRC stock go?
The most bullish Wall Street analyst has a price target of $N/A for NRC, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $70 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover NRC stock?
NRC is lightly followed, with 0 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the NRC stock forecast?
The 12-month NRC stock forecast based on 0 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "N/A". Our proprietary valuation model produces a base case fair value of $26, with bear/bull scenarios of $23/$70.
What is NRC's fair value based on fundamentals?
Our quantitative valuation model calculates NRC's fair value at $26 (base case), with a bear case of $23 and bull case of $70. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
What is NRC's forward P/E ratio?
NRC trades at a forward P/E ratio of 22.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 37.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy NRC stock?
NRC appears fairly valued according to analysts, with a "N/A" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do NRC price targets vary so much?
NRC analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $23-$70 range provides an independent fundamental perspective.